SENSEX NIFTY

Anu Labs

Feb 08, 2013 at 19:09 | Source: Moneycontrol.com
Anu's Laboratories has informed BSE that the Board of Directors of the Company at its meeting held on February 07, 2013. Issue of warrant / share / Convertible Debenture to the Promoter & Promoter Group.
Aug 27, 2012 at 10:19 | Source: CNBC-TV18
Anu Jain of IIFL Private Wealth Management advice traders to hold Ranbaxy Labs with stop loss of Rs 540.
Aug 06, 2011 at 10:31 | Source: Moneycontrol.com
Moneycontrol.com initiative, Know Your Investment, helps investors to take a prudent call on their investments. This week, Pankaj Pandey, head research desk of ICICIdirect.com, gave his outlook on various stocks that you wanted to know about.
Nov 29, 2010 at 13:53 | Source: CNBC-TV18
Ranbaxy Labs has reacted from previous resistance, it clicked down and then again it has moved up. So if it manages to cross that Rs 580 levels from which it is quite close to, then it may go to its previous highs closer to Rs 624, says Anu Jain, IIFL Private Wealth Management, India Infoline.
Sep 20, 2010 at 09:32 | Source: CNBC-TV18
Dr Reddys Laboratories has target of Rs 1520, says Anu Jain of IIFL Private Wealth Management.
Aug 30, 2010 at 11:07 | Source: CNBC-TV18
Natco Pharma can test Rs 280, says Anu Jain, IIFL Private Wealth Management, India Infoline.
Aug 26, 2010 at 09:43 | Source: CNBC-TV18
Ipca Lab can add 4-5%, says Anu Jain, IIFL Private Wealth Mgmt, India Infoline.
Jul 08, 2010 at 09:59 | Source: CNBC-TV18
Polaris Software Lab can test Rs 204-210, says Technical Analyst, Anu Jain.
Jun 10, 2010 at 11:25 | Source: CNBC-TV18
Anu Jain, Vice President of IIFL Private Wealth Management advises traders to buy into KPIT Cummins, Dr Reddys Labs and IVRCL. However, she is bearish on Wipro and Aban Offshore.
Jun 10, 2010 at 09:19 | Source: CNBC-TV18
Buy Dr Reddys Laboratories on dips, says Anu Jain, Vice President - IIFL Private Wealth Management.
Explore Moneycontrol

Copyright © e-Eighteen.com Ltd. All rights reserved. Reproduction of news articles, photos, videos or any other content in whole or in part in any form or medium without express written permission of moneycontrol.com is prohibited.